A Study of Depemokimab in Participants of 6 to 11 Years of Age

Part of paid clinical trials in Mobile, Alabama.

Sponsor
GlaxoSmithKline
Study ID
NCT07671001
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
6 Years - 11 Years
Healthy Volunteers
Not accepted

Interventions

  • Depemokimab — BIOLOGICAL
    Depemokimab will be administered.

Study Details

This study is aimed at assessing depemokimab as an add-on medicine for the treatment of asthma with type-2 inflammation in participants of 6 to 11 years of age. This study will test how the body processes depemokimab, how the drug works in the body, and its safety and tolerability.

Key Dates

First listed
Jun 26, 2026
Start date
Jun 25, 2026
Status verified
Aug 2026
Primary completion
Mar 1, 2027
Completion
Nov 24, 2028

Study Design

Enrollment
34 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Depemokimab
    Participants will receive depemokimab at doses based on their body weight.

Primary Outcome Measure

Depemokimab Concentration in Plasma [ Time Frame: Up to Week 52 ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
GSK Investigational SiteMobileAlabama36608
US GSK Clinical Trials Call Center
[email protected]
877-379-3718
EU GSK Clinical Trials Call Centre
[email protected]
+44 (0) 20 8990 4466
Lawrence Sindel (PRINCIPAL_INVESTIGATOR)
GSK Investigational SiteColorado SpringsColorado80923
US GSK Clinical Trials Call Center
[email protected]
877-379-3718
EU GSK Clinical Trials Call Centre
[email protected]
+44 (0) 20 8990 4466
Eric Caplan (PRINCIPAL_INVESTIGATOR)
GSK Investigational SiteWatertownSouth Dakota13601
US GSK Clinical Trials Call Center
[email protected]
877-379-3718
EU GSK Clinical Trials Call Centre
[email protected]
+44 (0) 20 8990 4466
Dariusz Chrostowski (PRINCIPAL_INVESTIGATOR)

Find similar trials in Mobile, AL

Nationwide
Asthma trialsPulmonology trialsLung disease trials
By condition
Asthma
By specialty
PulmonologyLung disease
By research site
GSK Investigational Site· Mobile, ALGSK Investigational Site· Colorado Springs, COGSK Investigational Site· Watertown, SD

Related Studies